SCHEMBL650323

SCHEMBL650323

Cc1c(-c2cccs2)sc(-c2cccs2)c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
KDM4E B2RXH2 9/20 0.42
ALDH1A1 P00352 8/20 0.42
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
MAPT P10636 3/20 0.41
HPGD P15428 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
GLA P06280 2/20 0.41
GAA P10253 2/20 0.41
LMNA P02545 1/20 0.41
LTA4H P09960 1/20 0.39
EPHX2 P34913 1/20 0.39
HSD17B10 Q99714 1/20 0.39
DPP4 P27487 3/20 0.39
HTT P42858 1/20 0.39
RCE1 Q9Y256 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16785685 0.88 MEN1 (0.42) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL13156364 0.87 DPP4 (0.50) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL12892637 0.86 MEN1 (0.43) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL14765524 0.83 MEN1 (0.41) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL9692168 0.82 SMN1; SMN2 (0.39) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL12788687 0.82 MEN1 (0.38) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL4319170 0.78 MEN1 (0.47) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL14351350 0.77 MEN1 (0.51) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL992406 0.77 MEN1 (0.38) MEN1KMT2AKDM4EALDH1A1RAB9A
SCHEMBL14765523 0.77 MEN1 (0.37) MEN1KMT2AKDM4EALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170267929-A1 DEVICE FOR REGULATING THE PASSAGE OF ENERGY MERCK PATENT GMBH (DE) 2017-09-21 US disclosed
US-8931114-B2 Elastomeric composites with tether-containing, conducting polymers for nanoscale diffusion control THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2015-01-13 US disclosed
US-20120073027-A1 Elastomeric Composites with Tether-Containing, Conducting Polymers for Nanoscale Diffusion Control THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-03-29 US disclosed
US-8120893-B2 Tether-containing conducting polymers THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-02-21 US disclosed
US-8120893-B2 Tether-containing conducting polymers THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-02-21 US disclosed
US-8120893-B2 Tether-containing conducting polymers THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2012-02-21 US disclosed
US-20100073847-A1 TETHER-CONTAINING CONDUCTING POLYMERS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2010-03-25 US disclosed
US-20100073847-A1 TETHER-CONTAINING CONDUCTING POLYMERS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2010-03-25 US disclosed
US-20100073847-A1 TETHER-CONTAINING CONDUCTING POLYMERS THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2010-03-25 US disclosed
WO-2010033966-A1 TETHER-CONTAINING CONDUCTING POLYMERS The Government of the United State of America, as represented by the Secretary of the Navy (US) 2010-03-25 WO disclosed
WO-2010033966-A1 TETHER-CONTAINING CONDUCTING POLYMERS The Government of the United State of America, as represented by the Secretary of the Navy (US) 2010-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120073027-A1 Elastomeric Composites with Tether-Containing, Conducting Polymers for Nanoscale Diffusion Control PIEZO1, TWF2, TMEM63A MEN1 851/4885KMT2A 3470/4885KDM4E 2437/4885
US-20100073847-A1 TETHER-CONTAINING CONDUCTING POLYMERS SPIN4, PAH, SMC4 MEN1 2447/4885KMT2A 1247/4885KDM4E 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.